HBM Healthcare Investments invests in the drugs and healthcare technology of tomorrow.
HBM Healthcare Investmants is an attractive alternative to investments in large pharmaceutical and biotech corporations.
HBM Healthcare Investments enables the development of promising new biotechnologies.
Successful IPO of Enanta increases the net asset value (NAV) per share by CHF 1.05.
Current share price and price development.
© HBM Healthcare Investments AG